The MEK/ERK Pathway Acts Upstream of NFκB1 (p50) Homodimer Activity and Bcl-2 Expression in a Murine B-Cell Lymphoma Cell Line
Open Access
- 1 August 2003
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 278 (34), 32465-32470
- https://doi.org/10.1074/jbc.m212919200
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- A Novel NF-κB-inducing Kinase-MAPK Signaling Pathway Up-regulates NF-κB Activity in Melanoma CellsPublished by Elsevier BV ,2002
- Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κBJCI Insight, 2001
- Phosphorylation Meets Ubiquitination: The Control of NF-κB ActivityAnnual Review of Immunology, 2000
- The role of NF-κB/IκB proteins in cancer: implications for novel treatment strategiesSurgical Oncology, 1999
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1Proceedings of the National Academy of Sciences of the United States of America, 1998
- Identification and Characterization of an IκB KinaseCell, 1997
- Activation of the IκBα Kinase Complex by MEKK1, a Kinase of the JNK PathwayCell, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996